Niox is used for managing airway inflammation by measuring exhaled nitric oxide (NO) levels. Aerocrine and Bioson entered into collaboration in 2004 for distributing Niox in the Chinese market. This agreement has now been expanded to include Niox Mino.
The Chinese market for asthma drugs is estimated to increase from SEK1.2 billion in 2006 to SEK2.3 billion in 2011. Aerocrine said that China represents a significant future prospect for the company.